Opioid Induced Constipation Drugs-United States Market Status and Trend Report 2013-2023
Report Summary
Opioid Induced Constipation Drugs-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Opioid Induced Constipation Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Opioid Induced Constipation Drugs 2013-2017, and development forecast 2018-2023
Main market players of Opioid Induced Constipation Drugs in United States, with company and product introduction, position in the Opioid Induced Constipation Drugs market
Market status and development trend of Opioid Induced Constipation Drugs by types and applications
Cost and profit status of Opioid Induced Constipation Drugs, and marketing status
Market growth drivers and challenges
The report segments the United States Opioid Induced Constipation Drugs market as:
United States Opioid Induced Constipation Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Opioid Induced Constipation Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
United States Opioid Induced Constipation Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
United States Opioid Induced Constipation Drugs Market: Players Segment Analysis (Company and Product introduction, Opioid Induced Constipation Drugs Sales Volume, Revenue, Price and Gross Margin):
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Opioid Induced Constipation Drugs-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Opioid Induced Constipation Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Opioid Induced Constipation Drugs 2013-2017, and development forecast 2018-2023
Main market players of Opioid Induced Constipation Drugs in United States, with company and product introduction, position in the Opioid Induced Constipation Drugs market
Market status and development trend of Opioid Induced Constipation Drugs by types and applications
Cost and profit status of Opioid Induced Constipation Drugs, and marketing status
Market growth drivers and challenges
The report segments the United States Opioid Induced Constipation Drugs market as:
United States Opioid Induced Constipation Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Opioid Induced Constipation Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
United States Opioid Induced Constipation Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
United States Opioid Induced Constipation Drugs Market: Players Segment Analysis (Company and Product introduction, Opioid Induced Constipation Drugs Sales Volume, Revenue, Price and Gross Margin):
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OVER-THE-COUNTER DRUGS
1.1 Definition of Over-the-Counter Drugs in This Report
1.2 Commercial Types of Over-the-Counter Drugs
1.2.1 Analgesics & Pain Relievers
1.2.2 Cough, Cold and Flu Products
1.2.3 Dermatological Products
1.2.4 Vitamin & Mineral Supplements
1.2.5 Gastrointestinal Products
1.2.6 Sleep Aids
1.2.7 Weight Loss Products
1.2.8 Smoking Cession Aids
1.2.9 Ophthalmic Products
1.2.10 Other
1.3 Downstream Application of Over-the-Counter Drugs
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Over-the-Counter Drugs
1.5 Market Status and Trend of Over-the-Counter Drugs 2013-2023
1.5.1 Global Over-the-Counter Drugs Market Status and Trend 2013-2023
1.5.2 Regional Over-the-Counter Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Over-the-Counter Drugs 2013-2017
2.2 Production Market of Over-the-Counter Drugs by Regions
2.2.1 Production Volume of Over-the-Counter Drugs by Regions
2.2.2 Production Value of Over-the-Counter Drugs by Regions
2.3 Demand Market of Over-the-Counter Drugs by Regions
2.4 Production and Demand Status of Over-the-Counter Drugs by Regions
2.4.1 Production and Demand Status of Over-the-Counter Drugs by Regions 2013-2017
2.4.2 Import and Export Status of Over-the-Counter Drugs by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Over-the-Counter Drugs by Types
3.2 Production Value of Over-the-Counter Drugs by Types
3.3 Market Forecast of Over-the-Counter Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Over-the-Counter Drugs by Downstream Industry
4.2 Market Forecast of Over-the-Counter Drugs by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OVER-THE-COUNTER DRUGS
5.1 Global Economy Situation and Trend Overview
5.2 Over-the-Counter Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 OVER-THE-COUNTER DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Over-the-Counter Drugs by Major Manufacturers
6.2 Production Value of Over-the-Counter Drugs by Major Manufacturers
6.3 Basic Information of Over-the-Counter Drugs by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Over-the-Counter Drugs Major Manufacturer
6.3.2 Employees and Revenue Level of Over-the-Counter Drugs Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OVER-THE-COUNTER DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson
7.1.1 Company profile
7.1.2 Representative Over-the-Counter Drugs Product
7.1.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.2 Merck
7.2.1 Company profile
7.2.2 Representative Over-the-Counter Drugs Product
7.2.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Merck
7.3 Novartis
7.3.1 Company profile
7.3.2 Representative Over-the-Counter Drugs Product
7.3.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Novartis
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Over-the-Counter Drugs Product
7.4.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Sanofi
7.5.1 Company profile
7.5.2 Representative Over-the-Counter Drugs Product
7.5.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Sanofi
7.6 Teva Pharmaceutical Industries
7.6.1 Company profile
7.6.2 Representative Over-the-Counter Drugs Product
7.6.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
7.7 Sun Pharmaceutical Industries
7.7.1 Company profile
7.7.2 Representative Over-the-Counter Drugs Product
7.7.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
7.8 GlaxoSmithKline
7.8.1 Company profile
7.8.2 Representative Over-the-Counter Drugs Product
7.8.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.9 Boehringer Ingelheim
7.9.1 Company profile
7.9.2 Representative Over-the-Counter Drugs Product
7.9.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.10 Bayer
7.10.1 Company profile
7.10.2 Representative Over-the-Counter Drugs Product
7.10.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Bayer
7.11 Alkem Laboratories
7.11.1 Company profile
7.11.2 Representative Over-the-Counter Drugs Product
7.11.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Alkem Laboratories
7.12 Glenmark Pharmaceuticals
7.12.1 Company profile
7.12.2 Representative Over-the-Counter Drugs Product
7.12.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Glenmark Pharmaceuticals
7.13 Cipla
7.13.1 Company profile
7.13.2 Representative Over-the-Counter Drugs Product
7.13.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Cipla
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OVER-THE-COUNTER DRUGS
8.1 Industry Chain of Over-the-Counter Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OVER-THE-COUNTER DRUGS
9.1 Cost Structure Analysis of Over-the-Counter Drugs
9.2 Raw Materials Cost Analysis of Over-the-Counter Drugs
9.3 Labor Cost Analysis of Over-the-Counter Drugs
9.4 Manufacturing Expenses Analysis of Over-the-Counter Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF OVER-THE-COUNTER DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Over-the-Counter Drugs in This Report
1.2 Commercial Types of Over-the-Counter Drugs
1.2.1 Analgesics & Pain Relievers
1.2.2 Cough, Cold and Flu Products
1.2.3 Dermatological Products
1.2.4 Vitamin & Mineral Supplements
1.2.5 Gastrointestinal Products
1.2.6 Sleep Aids
1.2.7 Weight Loss Products
1.2.8 Smoking Cession Aids
1.2.9 Ophthalmic Products
1.2.10 Other
1.3 Downstream Application of Over-the-Counter Drugs
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Over-the-Counter Drugs
1.5 Market Status and Trend of Over-the-Counter Drugs 2013-2023
1.5.1 Global Over-the-Counter Drugs Market Status and Trend 2013-2023
1.5.2 Regional Over-the-Counter Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Over-the-Counter Drugs 2013-2017
2.2 Production Market of Over-the-Counter Drugs by Regions
2.2.1 Production Volume of Over-the-Counter Drugs by Regions
2.2.2 Production Value of Over-the-Counter Drugs by Regions
2.3 Demand Market of Over-the-Counter Drugs by Regions
2.4 Production and Demand Status of Over-the-Counter Drugs by Regions
2.4.1 Production and Demand Status of Over-the-Counter Drugs by Regions 2013-2017
2.4.2 Import and Export Status of Over-the-Counter Drugs by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Over-the-Counter Drugs by Types
3.2 Production Value of Over-the-Counter Drugs by Types
3.3 Market Forecast of Over-the-Counter Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Over-the-Counter Drugs by Downstream Industry
4.2 Market Forecast of Over-the-Counter Drugs by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OVER-THE-COUNTER DRUGS
5.1 Global Economy Situation and Trend Overview
5.2 Over-the-Counter Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 OVER-THE-COUNTER DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Over-the-Counter Drugs by Major Manufacturers
6.2 Production Value of Over-the-Counter Drugs by Major Manufacturers
6.3 Basic Information of Over-the-Counter Drugs by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Over-the-Counter Drugs Major Manufacturer
6.3.2 Employees and Revenue Level of Over-the-Counter Drugs Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 OVER-THE-COUNTER DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Johnson & Johnson
7.1.1 Company profile
7.1.2 Representative Over-the-Counter Drugs Product
7.1.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.2 Merck
7.2.1 Company profile
7.2.2 Representative Over-the-Counter Drugs Product
7.2.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Merck
7.3 Novartis
7.3.1 Company profile
7.3.2 Representative Over-the-Counter Drugs Product
7.3.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Novartis
7.4 Pfizer
7.4.1 Company profile
7.4.2 Representative Over-the-Counter Drugs Product
7.4.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Pfizer
7.5 Sanofi
7.5.1 Company profile
7.5.2 Representative Over-the-Counter Drugs Product
7.5.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Sanofi
7.6 Teva Pharmaceutical Industries
7.6.1 Company profile
7.6.2 Representative Over-the-Counter Drugs Product
7.6.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries
7.7 Sun Pharmaceutical Industries
7.7.1 Company profile
7.7.2 Representative Over-the-Counter Drugs Product
7.7.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical Industries
7.8 GlaxoSmithKline
7.8.1 Company profile
7.8.2 Representative Over-the-Counter Drugs Product
7.8.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.9 Boehringer Ingelheim
7.9.1 Company profile
7.9.2 Representative Over-the-Counter Drugs Product
7.9.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.10 Bayer
7.10.1 Company profile
7.10.2 Representative Over-the-Counter Drugs Product
7.10.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Bayer
7.11 Alkem Laboratories
7.11.1 Company profile
7.11.2 Representative Over-the-Counter Drugs Product
7.11.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Alkem Laboratories
7.12 Glenmark Pharmaceuticals
7.12.1 Company profile
7.12.2 Representative Over-the-Counter Drugs Product
7.12.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Glenmark Pharmaceuticals
7.13 Cipla
7.13.1 Company profile
7.13.2 Representative Over-the-Counter Drugs Product
7.13.3 Over-the-Counter Drugs Sales, Revenue, Price and Gross Margin of Cipla
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OVER-THE-COUNTER DRUGS
8.1 Industry Chain of Over-the-Counter Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OVER-THE-COUNTER DRUGS
9.1 Cost Structure Analysis of Over-the-Counter Drugs
9.2 Raw Materials Cost Analysis of Over-the-Counter Drugs
9.3 Labor Cost Analysis of Over-the-Counter Drugs
9.4 Manufacturing Expenses Analysis of Over-the-Counter Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF OVER-THE-COUNTER DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
